Biogen alzheimer's drug shows positive results

3:58 PM ET Wed, 25 July 2018

CNBC's Meg Tirrell reports the latest on Biogen's new alzheimer's drug slowing disease progression and Sarepta Therapeutics' latest muscular dystrophy drug trial.